Heatbud logo
TOP CHARTS
BLOG POSTS
SEARCH
HELP CENTER
LOGIN / SIGNUP
MarketResearch Visit zone home page
Open Zone
Favorite
< Previous Post
> Next Post
Create a Post
Create a Zone
MY ZONES
Login to favorite zones.
TOP ZONES+
  • Finance
       
  • Finance
       
  • Industries
       
  • Business
       
  • Market ResearchNest
       
  • MarketResearch
       
  • Trendy Women Tops That Will Help You To Improve
       
  • eMarketOrg.com
       
  • Research Trades Business Report
       
  • My Zone
       
  • Car Accessories
       
  • Politics
       
  • Health
       
  • College
       
  • Global QYResearch
       
  • Yada Yada Yada
       
  • Singing Bowls
       
  • Market Research Report
       
  • Provue
       
  • AlgoroReports
       
anti-obesity prescription drugs market expected to a value of over US$ 1,000 Mn by the end of 2026
by
Share Blog Post by URL Like Heatbud on Facebook
UNIQUE VIEWS   +   UP VOTES Vote Up   -   DOWN VOTES Vote Down   +   COMMENTS Comments   =   HEAT INDEX What is Heat Index?

 

 

Global Anti-Obesity Prescription Drugs Market: Overview

 

The global anti-obesity prescription drugs market is expected to witness a moderate growth attributed to growing prevalence of obesity globally. Moreover, surge in consumption of unhealthy food products that are rich in cholesterol has led to an upsurge in demand anti-obesity prescription drugs. Increasing level of chronic stress also contributes towards obesity. Moreover, consumption of psychotropic and diabetic drugs is expected to impact growth of the global anti-obesity prescription drugs market during the forecast period.

 

The report provides an in-depth insight on some important aspects of the global anti-obesity prescription drugs market and offers insights on the growth patterns, various factors fuelling growth of the global market, competitive landscape and important segments.

 

View Report @ https://www.marketresearchreports.biz/reports/1391914/anti-obesity-prescription-drugs-global-market-research-reports

 

Global Anti-Obesity Prescription Drugs Market: Dynamics

 

Growth of the global anti-obesity prescription drugs market will mainly remain bound to various macro-economic and micro-economic factors. The report further reveals that the global anti-obesity prescription drugs market is increasingly driven by growing prevalence of obesity globally. Consumption of the food products that are rich in cholesterol continues to contribute towards obesity. Growing consumption of alcoholic beverages will also lead to increase in obesity during the forecast period.

 

Growing prevalence of depression has led to increasing consumption of the psychotropic drugs. Increasing side-effects of the psychotropic drug has contributed towards obesity. Growing prevalence of obesity due to increasing side-effects of psychotropic drugs has led to an upsurge in demand for obesity management. Moreover, increasing prevalence of diabetes has revved up consumption of medications such as sulfonylureas, insulin and thizolidinediones. These medications have appetite stimulating features, due to which the patients tend to eat more. Eating disorders due to antidepressants and diabetic drugs has continued to contribute towards obesity. Increasing demand for obesity management is expected to impact growth of the global anti-obesity prescription drugs market positively.

 

Obesity has also witnessed to be a result of increasing chronic stress globally. Increasing emotional and physical stress level leads the brain to release cortisol hormones. Release of the cortisol hormones further stimulates a persons appetite, due to which people tend to eat unhealthy food products. Increasing consumption of unhealthy food products helps people to counter their emotional and physical stress. Growing prevalence of obesity due to increasing level of stress has further led to an upsurge in demand for obesity management. Bound to these factors, the global anti-obesity prescription drugs market is expected to witness significant growth.

 

Get Sample Copy Of This Report @

https://www.marketresearchreports.biz/sample/sample/1391914

 

Global Anti-Obesity Prescription Drugs Market: Segmentation

 

The global anti-obesity prescription drugs market is mainly segmented into drug class, age group, distribution channel, and region. On the basis drug class, the global market is expected to be segmented as Bupropion and Naltrexone, Orlistat, Lorcaserin, Phentermine and Topiramate and Liraglutide. Based on age group, the global market is segmented as Pediatric and Adult. By distribution channel, the global market is segmented as Hospitals Pharmacies, Retail Pharmacies and E-commerce.

 

Global Anti-Obesity Prescription Drugs Market: Competition

 

Key players in the global anti-obesity prescription drugs market are VIVUS, Inc, Orexigen Therapeutics, Inc, Novo Nordisk A/S, F Hoffmann La Roche Ltd and Arena Pharmaceuticals, Inc.

 

Send An Enquiry Request @

https://www.marketresearchreports.biz/sample/enquiry/1391914

 

Table of Contents

1. Global Anti-Obesity Prescription Drugs Market - Executive Summary

 

2. Global Anti-Obesity Prescription Drugs Market Overview

2.1. Introduction

2.1.1. Global Anti-Obesity Prescription Drugs Market Taxonomy

2.1.2. Global Anti-Obesity Prescription Drugs Market Definition

2.2. Global Anti-Obesity Prescription Drugs Market Size (US$ Mn) and Forecast, 2012-2026

2.2.1. Global Anti-Obesity Prescription Drugs Market Y-o-Y Growth

2.3. Global Anti-Obesity Prescription Drugs Market Dynamics

2.4. Supply Chain

2.5. Cost Structure

2.6. Pricing Analysis

2.7. PESTLE Analysis

2.8. Product Life Cycle Analysis

2.9. Key Regulations

2.10. Patents

2.11. List of Distributors

2.12. Key Participants Market Presence (Intensity Map) By Region

 

3. Global Anti-Obesity Prescription Drugs Market Analysis and Forecast 2012-2026

3.1. Global Anti-Obesity Prescription Drugs Market Size and Forecast By Drug Class, 2012-2026

3.1.1. Bupropion and Naltrexone Market Size and Forecast, 2012-2026

3.1.1.1. Revenue (US$ Mn) Comparison, By Region

3.1.1.2. Market Share Comparison, By Region

3.1.1.3. Y-o-Y growth Comparison, By Region

3.1.2. Orlistat Market Size and Forecast, 2012-2026

3.1.2.1. Revenue (US$ Mn) Comparison, By Region

3.1.2.2. Market Share Comparison, By Region

3.1.2.3. Y-o-Y growth Comparison, By Region

3.1.3. Lorcaserin Market Size and Forecast, 2012-2026

3.1.3.1. Revenue (US$ Mn) Comparison, By Region

3.1.3.2. Market Share Comparison, By Region

3.1.3.3. Y-o-Y growth Comparison, By Region

3.1.4. Phentermine and Topiramate Market Size and Forecast, 2012-2026

3.1.4.1. Revenue (US$ Mn) Comparison, By Region

3.1.4.2. Market Share Comparison, By Region

3.1.4.3. Y-o-Y growth Comparison, By Region

3.1.5. Liraglutide Market Size and Forecast, 2012-2026

3.1.5.1. Revenue (US$ Mn) Comparison, By Region

3.1.5.2. Market Share Comparison, By Region

3.1.5.3. Y-o-Y growth Comparison, By Region

3.2. Global Anti-Obesity Prescription Drugs Market Size and Forecast By Age Group, 2012-2026

3.2.1. Pediatric Market Size and Forecast, 2012-2026

3.2.1.1. Revenue (US$ Mn) Comparison, By Region

3.2.1.2. Market Share Comparison, By Region

3.2.1.3. Y-o-Y growth Comparison, By Region

3.2.2. Adult Market Size and Forecast, 2012-2026

3.2.2.1. Revenue (US$ Mn) Comparison, By Region

3.2.2.2. Market Share Comparison, By Region

3.2.2.3. Y-o-Y growth Comparison, By Region

3.3. Global Anti-Obesity Prescription Drugs Market Size and Forecast By Distribution Channel, 2012-2026

3.3.1. Hospitals Pharmacies Market Size and Forecast, 2012-2026

3.3.1.1. Revenue (US$ Mn) Comparison, By Region

3.3.1.2. Market Share Comparison, By Region

3.3.1.3. Y-o-Y growth Comparison, By Region

3.3.2. Retail Pharmacies Market Size and Forecast, 2012-2026

3.3.2.1. Revenue (US$ Mn) Comparison, By Region

3.3.2.2. Market Share Comparison, By Region

3.3.2.3. Y-o-Y growth Comparison, By Region

3.3.3. E-commerce Market Size and Forecast, 2012-2026

3.3.3.1. Revenue (US$ Mn) Comparison, By Region

3.3.3.2. Market Share Comparison, By Region

3.3.3.3. Y-o-Y growth Comparison, By Region

 

4. North America Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026

4.1. Revenue (US$ Mn) Comparison, By Country

4.2. Revenue (US$ Mn) Comparison, By Drug Class

4.3. Revenue (US$ Mn) Comparison, By Age Group

4.4. Revenue (US$ Mn) Comparison, By Distribution Channel

 

5. Latin America Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026

5.1. Revenue (US$ Mn) Comparison, By Country

5.2. Revenue (US$ Mn) Comparison, By Drug Class

5.3. Revenue (US$ Mn) Comparison, By Age Group

5.4. Revenue (US$ Mn) Comparison, By Distribution Channel

 

6. Europe Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026

6.1. Revenue (US$ Mn) Comparison, By Country

6.2. Revenue (US$ Mn) Comparison, By Drug Class

6.3. Revenue (US$ Mn) Comparison, By Age Group

6.4. Revenue (US$ Mn) Comparison, By Distribution Channel

 

7. Japan Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026

7.1. Revenue (US$ Mn) Comparison, By Country

7.2. Revenue (US$ Mn) Comparison, By Drug Class

7.3. Revenue (US$ Mn) Comparison, By Age Group

7.4. Revenue (US$ Mn) Comparison, By Distribution Channel

 

About us

 

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

 

Contact

 

Mr. Nachiketa

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Comments:
0 blogger(s) are following this post, but not you. Follow?
No comments yet.
 
Post a Comment:

 
Related Posts: